ALGN
Price
$221.79
Change
+$6.76 (+3.14%)
Updated
Nov 14, 03:13 PM (EDT)
76 days until earnings call
ARAY
Price
$1.78
Change
-$0.03 (-1.66%)
Updated
Nov 14, 03:12 PM (EDT)
69 days until earnings call
Ad is loading...

ALGN vs ARAY

Header iconALGN vs ARAY Comparison
Open Charts ALGN vs ARAYBanner chart's image
Align Technology
Price$221.79
Change+$6.76 (+3.14%)
Volume$100
CapitalizationN/A
Accuray
Price$1.78
Change-$0.03 (-1.66%)
Volume$100
CapitalizationN/A
ALGN vs ARAY Comparison Chart
Loading...
ALGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ARAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ALGN vs. ARAY commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a StrongSell and ARAY is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (ALGN: $215.04 vs. ARAY: $1.81)
Brand notoriety: ALGN: Notable vs. ARAY: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ALGN: 75% vs. ARAY: 111%
Market capitalization -- ALGN: $24.63B vs. ARAY: $244.95M
ALGN [@Medical Specialties] is valued at $24.63B. ARAY’s [@Medical Specialties] market capitalization is $244.95M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 0 FA rating(s) are green whileARAY’s FA Score has 0 green FA rating(s).

  • ALGN’s FA Score: 0 green, 5 red.
  • ARAY’s FA Score: 0 green, 5 red.
According to our system of comparison, ARAY is a better buy in the long-term than ALGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 4 TA indicator(s) are bullish while ARAY’s TA Score has 3 bullish TA indicator(s).

  • ALGN’s TA Score: 4 bullish, 6 bearish.
  • ARAY’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ALGN is a better buy in the short-term than ARAY.

Price Growth

ALGN (@Medical Specialties) experienced а -4.36% price change this week, while ARAY (@Medical Specialties) price change was -10.84% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.85%. For the same industry, the average monthly price growth was +1.00%, and the average quarterly price growth was -4.44%.

Reported Earning Dates

ALGN is expected to report earnings on Jan 29, 2025.

ARAY is expected to report earnings on Jan 22, 2025.

Industries' Descriptions

@Medical Specialties (-1.85% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALGN($24.6B) has a higher market cap than ARAY($245M). ALGN YTD gains are higher at: -21.518 vs. ARAY (-36.042). ALGN has higher annual earnings (EBITDA): 799M vs. ARAY (5.93M). ALGN has more cash in the bank: 973M vs. ARAY (72.8M). ALGN has less debt than ARAY: ALGN (127M) vs ARAY (202M). ALGN has higher revenues than ARAY: ALGN (3.86B) vs ARAY (447M).
ALGNARAYALGN / ARAY
Capitalization24.6B245M10,041%
EBITDA799M5.93M13,469%
Gain YTD-21.518-36.04260%
P/E Ratio55.01N/A-
Revenue3.86B447M864%
Total Cash973M72.8M1,337%
Total Debt127M202M63%
FUNDAMENTALS RATINGS
ALGN vs ARAY: Fundamental Ratings
ALGN
ARAY
OUTLOOK RATING
1..100
420
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
98100
SMR RATING
1..100
6295
PRICE GROWTH RATING
1..100
5847
P/E GROWTH RATING
1..100
8161
SEASONALITY SCORE
1..100
5035

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALGN's Valuation (74) in the Medical Specialties industry is in the same range as ARAY (82). This means that ALGN’s stock grew similarly to ARAY’s over the last 12 months.

ALGN's Profit vs Risk Rating (98) in the Medical Specialties industry is in the same range as ARAY (100). This means that ALGN’s stock grew similarly to ARAY’s over the last 12 months.

ALGN's SMR Rating (62) in the Medical Specialties industry is somewhat better than the same rating for ARAY (95). This means that ALGN’s stock grew somewhat faster than ARAY’s over the last 12 months.

ARAY's Price Growth Rating (47) in the Medical Specialties industry is in the same range as ALGN (58). This means that ARAY’s stock grew similarly to ALGN’s over the last 12 months.

ARAY's P/E Growth Rating (61) in the Medical Specialties industry is in the same range as ALGN (81). This means that ARAY’s stock grew similarly to ALGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNARAY
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 9 days ago
74%
Bullish Trend 7 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
View a ticker or compare two or three
Ad is loading...
ALGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ARAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYRCX41.600.21
+0.51%
Rydex Retailing C
JHJAX25.70N/A
N/A
JHancock ESG Large Cap Core A
GMHPX14.17N/A
N/A
Goldman Sachs Rising Dividend Gr P
AMAGX84.12-0.22
-0.26%
Amana Growth Investor
GTDIX33.27-0.15
-0.45%
Invesco EQV Emerging Markets All Cap R5

ALGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGN has been loosely correlated with NVST. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGN jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGN
1D Price
Change %
ALGN100%
-1.85%
NVST - ALGN
53%
Loosely correlated
-0.88%
STAA - ALGN
50%
Loosely correlated
-2.00%
SAUHY - ALGN
49%
Loosely correlated
-1.59%
TWST - ALGN
49%
Loosely correlated
-6.16%
KIDS - ALGN
48%
Loosely correlated
+0.87%
More

ARAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARAY has been loosely correlated with BRKR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ARAY jumps, then BRKR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARAY
1D Price
Change %
ARAY100%
-5.24%
BRKR - ARAY
41%
Loosely correlated
-0.12%
BNGO - ARAY
39%
Loosely correlated
+4.53%
IQV - ARAY
38%
Loosely correlated
-0.96%
LH - ARAY
38%
Loosely correlated
+0.80%
ALGN - ARAY
38%
Loosely correlated
-1.85%
More